期刊文献+

人白细胞介素10基因慢病毒载体的构建及重组 被引量:1

The construction of recombinant lentiviral-vector with human interleukin-10 gene
下载PDF
导出
摘要 目的拟构建含人白细胞介素10(hIL-10)基因的慢病毒载体(LV-hIL-10),为进一步探讨慢性疼痛的治疗研究奠定基础。方法从pCYIL-10质粒中选择适当的引物进行PCR后得到含PmeI多功能酶切位点的IL-10基因片段,将其构建到慢病毒载体pWPXL上得到重组的pWPXL-IL-10质粒,对所抽提的质粒进行酶切及测序检测正确后大量提取备用。将重组质粒pWPXL-IL-10、包膜质粒pMD2.G和包装质粒psPAX2共转染293T细胞后包装出复制缺陷的慢病毒颗粒,进行病毒滴度的测定。结果重组质粒酶切鉴定结果显示,pWPXL-IL-10质粒中有一个530bp左右的插入片断,大小与IL-l0cDNA(534bp)基本符合。测序结果显示pWPXL-IL-10质粒上插入片段的序列与基因库中hIL-10基因序列完全一致。转染后获得了高滴度(2×1010)、高纯度的病毒颗粒。结论成功构建了含人白细胞介素10基因的慢病毒载体LV-hIL-10,为慢性疼痛治疗的研究奠定了基础。 Objective To construct contains human interleukin-10 gene recombinant lentiviral-vector (LV-IL-10) and to form a basis to further explore the therapy of chronic pain, Methods hIL-10 gene fragment was isolated and amplified from pCYIL-10 plasmid by PCR, and was cloned into pWPXL-GFP. The inserted hIL-10 fragment was verified by Pme I digestion and DNA sequencing. The recombinant plasmid pWPXL-IL-10-GFP, envelope plasmid pMD2. G and packaging plasmid psPAX2 were cotransfected into 293T cells, to pack out lentivirus particle that has the ability of duplicated-deficiency, then virus titer determination was undertaken. Results The 530bp IL-10 gene fragment was amplified from pCYIL-10 plasmid by PCR, and was recombinated into pWPXL-GFP plasmid. DNA sequencing confirmed that the cloned gene segment was 100% homologous to the published hIL-10 sequence in genebank. High titer(2 × 10^10) and highly purified lentiviral particles was obtained. Conclusions The lentivirus vector LV-hIL-10 was constructed successfully, which form a basis of research of chronic pain therapy.
出处 《中国普通外科杂志》 CAS CSCD 2008年第8期793-797,共5页 China Journal of General Surgery
基金 湖南省自然科学基金资助(06JJ4122)
关键词 慢病毒载体 人白细胞介素10 治疗 基因 Lentiviral- vector Human IL- 10 Therapy, Gene
  • 相关文献

参考文献19

  • 1VandenDriessche T, Vanslembrouck V, Goovaerts I, et al. Long-term expression of human coagμlation factor and correction of hemophilia after in vivo retreviral gene transfer in factor-VIIIdeficient mice [ J ]. Proc Natl Aead Scl USA, 1999.96(18) :10379- 10384.
  • 2Connelly S,Smith TA, Dhir G, et al. In vivo delivery and expression of physiological levels of functional human factor- VIII in mice[J]. Hum GeneTher, 1995 Feb;6(2) :185 -193.
  • 3Naldini L, Blonler U, Gallay P, et al. In vivo gene delivery. and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 1996,272(5259) :263 -267.
  • 4Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors[J]. 1997,17(3) :314 -317.
  • 5Milligan ED, Langer SJ, Sloane EM, et al. Controlling pathological pain by adenovirally driven spinal production of the antiinflammatory cytokine , interleukin- 10 [ J ] . Eur J Neurosci, 2005,21 (8) :2136-2148.
  • 6Milligan ED, Sloane EM, Langer SJ, et al. Controlling neuropathic pain by adeno-associated virus driven production of the anti- inflammatory cytokine, interleukin- 10 [ J ] . Mol Pain, 2005,25(1) :9 -22.
  • 7Hanawa H, Persons DA, Nienhuis AW. Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors [ J]. J Virol, 2005, 79 ( 13 ) : 8410 - 8421.
  • 8Logan AC, Haas DL, Kafri T, et al. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration [ J ]. J Virol, 2004,78(16) :8421 -8436.
  • 9Cockrell AS, Ma H, Fu K, et al. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV- 1 vectors [ J ] . Mol Ther, 2006,14 (2) :276 - 284.
  • 10Semple-Rowland SL, Eccles KS, Humberstone EJ. Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters[J]. Mol Vis, 2007,18(13) :2001 - 2011.

二级参考文献8

  • 1Vanden-Driessche T, Vanslembrouck V, Goovaerts I, et al.Long-term expression of human coagulation factor Ⅷ and correction of hemophilia A after in vivo retroviral gene transfer in factor Ⅷ-deficient mice. Proc Natl Acad Sci U S A, 1999, 96:10379-10384.
  • 2Connelly S, Smith TA, Dhir G, et al. In vivo delivery and expression of physiological levels of functional human factor Ⅷ in mice. Hum GeneTher, 1995,6:185-193.
  • 3Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 1996,272:263-267.
  • 4Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.Nat Genet, 1997,17:314-317.
  • 5Xu K, Ma H, McCown TJ, et al. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther, 2001,3:97-104.
  • 6Buchschacher GL Jr, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood, 2000, 95:2499-2504.
  • 7Sirven A, Pflumio F, Zennou V, et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood, 2000,96: 4103-4110.
  • 8Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther, 2001, 4:164-173.

共引文献20

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部